Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24)
The summary for the Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24): The complexity and pace of biomedical science often requires input and expertise from many more than one investigator. Currently support for collaborative research takes the form of a large R01 with one Principal Investigator (PI) and one or more key personnel,, a multi-PI R01, or a Program Project Grant (P01) with 3 or more individual and independent projects and cores centered on a common theme, or a Center supporting a focused set of activities. Other large research mechanisms often utilize cooperative agreements that also entail significant involvement of the NIH in the planning and execution of research objectives. In large collaborative studies synergies are built out of the interactions between and among the projects and investigators of these focused efforts. It is becoming clear that mechanism(s) to support collaborative (team) science in ways not amenable to the R01, P01, or Center are needed to address complex problems in biomedical sciences that require multiple and often different expertise. In 2003 the Bioengineering Consortium of the NIH held a workshop entitled Catalyzing Team Science that focused on the need to bring to bear multiple and differing expertise on problems that were of a complexity and scope that called for the need to apply a team approach to the problem.
Federal Grant Title: | Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases (R24) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-07-188 |
Type of Funding: | Grant |
CFDA Numbers: | 93.847 |
CFDA Descriptions: | Diabetes, Endocrinology and Metabolism Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Posted Date: | Dec 19, 2006 |
Creation Date: | Dec 19, 2006 |
Archive Date: | Mar 24, 2008 |
Total Program Funding: | $750,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Small businesses For profit organizations other than small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial...
- • Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial...
- • Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortiu...
- • Diabetes Research Centers (P30 Clinical Trial Optional)
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
- • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...